Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin
Alejandro Losada(PharmaMar (Spain)), Carlos M. Galmarini(Artificial Intelligence Research Institute)
Cited by 95
Related Papers
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
|Science|2021|364
Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survival
|British Journal of Cancer|2018|39
Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines
|Journal of Breast Cancer|2015|28
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™
|British Journal of Cancer|2004|26
Plitidepsin as an Immunomodulator against Respiratory Viral Infections
|The Journal of Immunology|2024|6